Another top exec has departed buzzy cannabis company MedMen
- David Dancer, MedMen's chief marketing officer, has left the company after less than a year, Business Insider has learned.
- Other top executives left in April, and the company faces a lawsuit alleging wrongful termination by ex-CFO James Parker.
- Dancer, whose career has spanned companies including Teleflora, Charles Schwab, Visa, and American Express, was hired by MedMen in July 2018 to help expand its North American retail footprint.
- Click here for more BI Prime stories.
David Dancer, MedMen's chief marketing officer, has left the company in June after less than a year, Business Insider has learned.
Dancer, whose career has spanned companies including Teleflora, Charles Schwab, Visa and American Express, was hired by MedMen in July 2018 as it sought to expand its North American retail footprint.
MedMen did not immediately respond for a request for comment.
MedMen has been at the forefront of trying to make pot mainstream with its sleek stores in high-profile locations. It also enlisted Spike Jonze to make a two-minute film, narrating the evolution of weed over time.
At MedMen, Dancer built the company's marketing and insights practice, heading a 40-person team, according to his LinkedIn, which doesn't reflect his departure. He also led MedMen's in-house ad agency.
His departure comes amid other exits and concerns at the marijuana retailer that were raised by ex-CFO James Parker. Parker in February filed a wrongful dismissal suit against the company, raising concerns of overspending and an unhealthy work environment, the Los Angeles Times reported. MedMen denied the allegations.
In April, chief operating officer Ben Cook, general counsel Lisa Sergi Trager, and SVP of corporate communications Daniel Yi quit amid a broader shakeup at the company, according to CNBC.
MedMen is traded on the Canadian Securities Exchange. It went public last May through a reverse takeover, when it bought an existing Canadian public company called Ladera Ventures. In its latest quarterly earnings, MedMen reported a loss of $63.1 million on revenue of $36.6 million.